Erratum: Endothelial p130cas confers resistance to anti-angiogenesis therapy (Cell Reports (2022) 38(4), (S2211124722000134), (10.1016/j.celrep.2022.110301))

Yunfei Wen, Anca Chelariu-Raicu, Sujanitha Umamaheswaran, Alpa M. Nick, Elaine Stur, Pahul Hanjra, Dahai Jiang, Nicholas B. Jennings, Xiuhui Chen, Sara Corvigno, Deanna Glassman, Gabriel Lopez-Berestein, Jinsong Liu, Mien Chie Hung, Anil K. Sood

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Abstract

(Cell Reports 38, 110301; January 25, 2022) In the original version of the article that was published with the January 25, 2022 issue, there were inadvertent errors introduced during figure assembly in Figures 2, 4, and 5. The original Figure 2H contained an inversion of the first two images in the upper panel, the original Figure 4D contained duplicated Hoechst and VEGFR2 images in row 1 and row 2 as well as a duplicated cell cluster in row 3, and the original Figure 5A contained duplicated animal images in day 35 (first group, positions 1 and 3) and day 50 (second group, positions 2 and 3). The correct images for each case have been located, and the correct versions of the figures now appear online with the article; these errors did not affect the scientific conclusions drawn from the figures. The authors sincerely regret the errors and any confusion they may have caused.[Formula

Original languageEnglish (US)
Article number110999
JournalCell Reports
Volume39
Issue number12
DOIs
StatePublished - Jun 21 2022

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Erratum: Endothelial p130cas confers resistance to anti-angiogenesis therapy (Cell Reports (2022) 38(4), (S2211124722000134), (10.1016/j.celrep.2022.110301))'. Together they form a unique fingerprint.

Cite this